{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:23Z","timestamp":1791996083407,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.burns.2021.08.016","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T11:00:27Z","timestamp":1630666827000},"page":"1495-1501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Continuous infusion versus intermittent infusion vancomycin in a burn center intensive care unit"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3092-4357","authenticated-orcid":false,"given":"Cory J.","family":"Schlobohm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2643-5040","authenticated-orcid":false,"given":"Elizabeth","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah J.","family":"Duby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.burns.2021.08.016_bib0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.TA.0000029382.26295.AB","article-title":"The risk factors and time course of sepsis and organ dysfunction after burn trauma","volume":"54","author":"Fitzwater","year":"2003","journal-title":"J Trauma"},{"issue":"1","key":"10.1016\/j.burns.2021.08.016_bib0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13756-021-00969-w","article-title":"Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study","volume":"10","author":"Hu","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.burns.2021.08.016_bib0015","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1097\/BCR.0000000000000147","article-title":"Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature","volume":"36","author":"Ortwine","year":"2015","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2021.08.016_bib0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/BCR.0000000000000438","article-title":"Risk factors for acute kidney injury in patients with burn injury: a meta-analysis and systematic review","volume":"38","author":"Wu","year":"2017","journal-title":"J Burn Care Res"},{"issue":"December (12)","key":"10.1016\/j.burns.2021.08.016_bib0025","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/CCM.0000000000000514","article-title":"Vancomycin-associated nephrotoxicity in the critically ill: aretrospective multivariate regression analysis","volume":"42","author":"Hanrahan","year":"2014","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.burns.2021.08.016_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2015.06.012","article-title":"Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients","volume":"30","author":"Hong","year":"2015","journal-title":"J Crit Care"},{"issue":"6","key":"10.1016\/j.burns.2021.08.016_bib0035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0885066618768749","article-title":"Evaluation of continuous infusion vancomycin administration in a critically ill trauma population","volume":"35","author":"Bissell","year":"2020","journal-title":"J Intensive Care Med"},{"issue":"6","key":"10.1016\/j.burns.2021.08.016_bib0040","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/CCM.0000000000004326","article-title":"Continuous versus intermittent infusion of vancomycin and the risk of acute kidney injury in critically ill adults: a systematic review and meta-analysis","volume":"48","author":"Flannery","year":"2020","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.burns.2021.08.016_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"5","key":"10.1016\/j.burns.2021.08.016_bib0050","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/AAC.01149-08","article-title":"Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients","volume":"53","author":"Pea","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.burns.2021.08.016_bib0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.burns.2021.08.016_bib0060","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.burns.2021.08.016_bib0065","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1097\/BCR.0b013e31825042fa","article-title":"Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy","volume":"33","author":"Akers","year":"2012","journal-title":"J Burn Care Res"},{"issue":"June (6)","key":"10.1016\/j.burns.2021.08.016_bib0070","first-page":"717","article-title":"Correlation of predicted versus measured creatinine clearance values in burn patients","volume":"35","author":"Lott","year":"1978","journal-title":"Am J Hosp Pharm"},{"issue":"9","key":"10.1016\/j.burns.2021.08.016_bib0075","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40262-018-0636-7","article-title":"Augmented renal clearance in critically ill patients: a systematic review","volume":"57","author":"Bilbao-meseguer","year":"2018","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.burns.2021.08.016_bib0080","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1309\/AJCPDSYS0DVLKFOH","article-title":"What proportion of vancomycin trough levels are drawn too early?","volume":"137","author":"Morrison","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.burns.2021.08.016_bib0085","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health System Pharm"},{"issue":"13","key":"10.1016\/j.burns.2021.08.016_bib0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417921002369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417921002369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T08:16:52Z","timestamp":1759652212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417921002369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0305417921002369"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2021.08.016","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous infusion versus intermittent infusion vancomycin in a burn center intensive care unit","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2021.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}